Literature DB >> 20631340

Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life.

Craig Nichols, Christian Kollmannsberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20631340     DOI: 10.1093/jnci/djq266

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

Review 1.  Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment.

Authors:  Bilal A Siddiqui; Miao Zhang; Louis L Pisters; Shi-Ming Tu
Journal:  Transl Androl Urol       Date:  2020-01

2.  Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.

Authors:  Samuel A Funt; Deaglan J McHugh; Stephanie Tsai; Andrea Knezevic; Devon O'Donnell; Sujata Patil; Deborah Silber; Maria Bromberg; Maryann Carousso; Victor E Reuter; Brett S Carver; Joel Sheinfeld; Robert J Motzer; Dean F Bajorin; George J Bosl; Darren R Feldman
Journal:  Oncologist       Date:  2021-03-12

3.  Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.

Authors:  Lucia Nappi; Margaret Ottaviano; Pasquale Rescigno; Marianna Tortora; Giuseppe L Banna; Giulia Baciarello; Umberto Basso; Christina Canil; Alessia Cavo; Maria Cossu Rocca; Piotr Czaykowski; Ugo De Giorgi; Xavier Garcia Del Muro; Marilena Di Napoli; Giuseppe Fornarini; Jourik A Gietema; Daniel Y C Heng; Sebastien J Hotte; Christian Kollmannsberger; Marco Maruzzo; Carlo Messina; Franco Morelli; Sasja Mulder; Craig Nichols; Franco Nolè; Christoph Oing; Teodoro Sava; Simona Secondino; Giuseppe Simone; Denis Soulieres; Bruno Vincenzi; Paolo A Zucali; Sabino De Placido; Giovannella Palmieri
Journal:  Oncologist       Date:  2020-09-18       Impact factor: 5.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.